Shoba Gopalan has served as Vice President, Head of Program Management and Alliance Management at Synthekine since August 2021. Shoba brings a wealth of experience and a track record of excellence working in similar roles. Prior to joining Synthekine, Shoba was most recently at ChemoCentryx, where she was instrumental in clinical study closeout, NDA preparation and file submission. She also led commercial launch readiness preparation for the company’s first approved product for treating auto-immune diseases and cancer. Additionally, Shoba has held senior program management roles at Portola Pharmaceuticals, Actelion Pharmaceuticals and Genomic Health, where she fostered collaboration and successfully led product development and launch teams for multiple programs. Earlier in her career, Shoba worked as a Postdoctoral Research Fellow at the University of California, Irvine after receiving her Ph.D. in Molecular Biology and Biochemistry from the University of Southern California.
Copyright 2022 – Synthekine